TY - JOUR
T1 - DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras
AU - Soejima, Kenzo
AU - Fang, Weizhao
AU - Rollins, Barrett J.
N1 - Funding Information:
We thank Drs En Li and Masaki Okano for Dnmt3b−/−MEFs and advice; Drs James DeCaprio, Matthew Meyerson, Jeong Wu Lee, Takahiro Arai, Seitaro Fujishima, and Chiaki Takahashi for reagents and helpful comments; and Christine Penta for administrative assistance. The work was supported by the Novartis/Dana-Farber Drug Discovery Program (BJR), and the Uehara Memorial Foundation (KS).
PY - 2003/7/24
Y1 - 2003/7/24
N2 - Transcriptional silencing of tumor suppressor genes in association with DNA methylation contributes to malignant transformation. However, the specific DNA methyltransferases that initiate this process are unknown. Here we show that a de novo DNA methyltransferase, DNMT3b, substantially contributes to the oncogenic phenotype in a lung cancer model. Normal human bronchial epithelial (NHBE) cells expressing telomerase, SV40 large T antigen, and activated Ras were immortal, formed colonies in soft agar, and expressed DNMT3b. Antisense suppression of DNMT3b prevented soft agar growth. Furthermore, mouse embryo fibroblasts expressing T antigen and Ras formed soft agar colonies and large tumors, but fibroblasts from Dnmt3b-/- mice did not grow in soft agar and were much less tumorigenic in vivo. The tumor suppressor genes, FHIT, TSLC1, and RASSF1A were downregulated in transformed NHBE cells, and antisense DNMT3b treatment resulted in re-expression of FHIT and TSLC1. While expression of TSCL1 correlated with methylation of CpG dinucleotides in its promoter region, the expression of FHIT did not, suggesting that DNMT3b may silence genes by several mechanisms including direct DNA methylation or recruitment of proteins that modify chromatin. Regardless of mechanism, our data indicate that DNMT3b plays an important role in transformation.
AB - Transcriptional silencing of tumor suppressor genes in association with DNA methylation contributes to malignant transformation. However, the specific DNA methyltransferases that initiate this process are unknown. Here we show that a de novo DNA methyltransferase, DNMT3b, substantially contributes to the oncogenic phenotype in a lung cancer model. Normal human bronchial epithelial (NHBE) cells expressing telomerase, SV40 large T antigen, and activated Ras were immortal, formed colonies in soft agar, and expressed DNMT3b. Antisense suppression of DNMT3b prevented soft agar growth. Furthermore, mouse embryo fibroblasts expressing T antigen and Ras formed soft agar colonies and large tumors, but fibroblasts from Dnmt3b-/- mice did not grow in soft agar and were much less tumorigenic in vivo. The tumor suppressor genes, FHIT, TSLC1, and RASSF1A were downregulated in transformed NHBE cells, and antisense DNMT3b treatment resulted in re-expression of FHIT and TSLC1. While expression of TSCL1 correlated with methylation of CpG dinucleotides in its promoter region, the expression of FHIT did not, suggesting that DNMT3b may silence genes by several mechanisms including direct DNA methylation or recruitment of proteins that modify chromatin. Regardless of mechanism, our data indicate that DNMT3b plays an important role in transformation.
KW - DNA methyltransferase
KW - Lung cancer
KW - Tumor suppressor
UR - http://www.scopus.com/inward/record.url?scp=0042090217&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0042090217&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1206510
DO - 10.1038/sj.onc.1206510
M3 - Article
C2 - 12879017
AN - SCOPUS:0042090217
SN - 0950-9232
VL - 22
SP - 4723
EP - 4733
JO - Oncogene
JF - Oncogene
IS - 30
ER -